Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis. // Clinical Neurology and Neurosurgery. – URL: https://www.sciencedirect.com/science/article/pii/S0303846726003161?dgcid=rss_sd_all
Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis. Clinical Neurology and Neurosurgery. https://www.sciencedirect.com/science/article/pii/S0303846726003161?dgcid=rss_sd_all
“Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis.” Clinical Neurology and Neurosurgery.
@article{article93559,
title = {Rituximab treatment in AChR-positive generalized myasthenia gravis within two years of diagnosis},
journal = {Clinical Neurology and Neurosurgery},
url = {https://www.sciencedirect.com/science/article/pii/S0303846726003161?dgcid=rss_sd_all}
}